Myeloproliferative neoplasm differential diagnosis: Difference between revisions
No edit summary |
(Mahshid) |
||
| Line 69: | Line 69: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
Revision as of 02:52, 27 November 2017
|
Myeloproliferative Neoplasm Microchapters |
|
Differentiating myeloproliferative neoplasm from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Myeloproliferative neoplasm differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Myeloproliferative neoplasm differential diagnosis |
|
Myeloproliferative neoplasm differential diagnosis in the news |
|
Directions to Hospitals Treating Myeloproliferative neoplasm |
|
Risk calculators and risk factors for Myeloproliferative neoplasm differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Myeloproliferative neoplasm must be differentiated from acute lymphoblastic leukemia, acute myelogenous leukemia, chronic myelogenous leukemia, essential thrombocytosis, hypereosinophilic syndrome, non-Hodgkin lymphoma, primary myelofibrosis, secondary thrombocytosis, splenomegaly, systemic mastocytosis, and waldenstrom macroglobulinemia.[1] [2]
Differentiating Myeloproliferative neoplasm from other Diseases
Myeloproliferative neoplasm must be differentiated from:[3] [4]
- Acute lymphoblastic leukemia
- Acute myelogenous leukemia
- Chronic myelogenous leukemia
- Essential thrombocytosis
- Hypereosinophilic syndrome
- Non-Hodgkin lymphoma
- Primary myelofibrosis
- Secondary thrombocytosis
- Splenomegaly
- Systemic mastocytosis
- Waldenstrom macroglobulinemia
References
- ↑ James W. Vardiman, Nancy Lee Harris & Richard D. Brunning (2002). "The World Health Organization (WHO) classification of the myeloid neoplasms". Blood. 100 (7): 2292–2302. doi:10.1182/blood-2002-04-1199. PMID 12239137. Unknown parameter
|month=ignored (help) - ↑ A. Tefferi, L. A. Solberg & M. N. Silverstein (2000). "A clinical update in polycythemia vera and essential thrombocythemia". The American journal of medicine. 109 (2): 141–149. PMID 10967156. Unknown parameter
|month=ignored (help) - ↑ James W. Vardiman, Nancy Lee Harris & Richard D. Brunning (2002). "The World Health Organization (WHO) classification of the myeloid neoplasms". Blood. 100 (7): 2292–2302. doi:10.1182/blood-2002-04-1199. PMID 12239137. Unknown parameter
|month=ignored (help) - ↑ A. Tefferi, L. A. Solberg & M. N. Silverstein (2000). "A clinical update in polycythemia vera and essential thrombocythemia". The American journal of medicine. 109 (2): 141–149. PMID 10967156. Unknown parameter
|month=ignored (help)